Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Tea’s value as a cancer therapy is steeped in uncertainty

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 566, S6-S7 (2019)


This article is part of Nature Outlook: Tea, an editorially independent supplement produced with the financial support of third parties. About this content.


  1. Yang, C. S., Wang, X., Lu, G. & Picinich, S. C. Nature Rev. Cancer 9, 429–439 (2009).

    Article  PubMed  Google Scholar 

  2. Gao, Y. T. et al. J. Natl Cancer Inst. 86, 855–858 (1994).

    Article  PubMed  Google Scholar 

  3. Liu, J. et al. Eur. J. Epidemiol. 31, 853–865 (2016).

    Article  PubMed  Google Scholar 

  4. van den Brandt, P. A. Eur. J. Epidemiol. 33, 183–200 (2018).

    Article  PubMed  Google Scholar 

  5. Shin, C. M. et al. Clin. Nutr. 37, 452–458 (2018).

    Article  PubMed  Google Scholar 

  6. Bettuzzi, S. et al. Cancer Res. 66, 1234–1240 (2006).

    Article  PubMed  Google Scholar 

  7. Chung, J. E. et al. Nature Nanotechnol. 9, 907–912 (2014).

    Article  PubMed  Google Scholar 

Download references


Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links